Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management
MA Gertz - American journal of hematology, 2023 - Wiley Online Library
Abstract Disease Overview Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management
MA Gertz - American journal of hematology, 2017 - Wiley Online Library
Disease Overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management
MA Gertz - American journal of hematology, 2021 - mayoclinic.elsevierpure.com
Abstract Disease Overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management
MA Gertz - American journal of hematology, 2019 - Wiley Online Library
Disease Overview Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management
MA Gertz - American journal of hematology, 2013 - pubmed.ncbi.nlm.nih.gov
Disease overview Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management
MA Gertz - American journal of hematology, 2012 - pubmed.ncbi.nlm.nih.gov
Disease overview Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management
MA Gertz - American journal of hematology, 2011 - Wiley Online Library
Disease overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management.
MA Gertz - American journal of hematology, 2015 - europepmc.org
Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and
management. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
management. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
Management of Waldenström macroglobulinemia in 2020
JJ Castillo, SP Treon - Hematology 2014, the American Society …, 2020 - ashpublications.org
The management of Waldenström macroglobulinemia (WM) has evolved tremendously with
recent genomic discoveries that correlate with clinical presentation and could help to tailor …
recent genomic discoveries that correlate with clinical presentation and could help to tailor …
How I treat Waldenström macroglobulinemia
SP Treon - Blood, The Journal of the American Society of …, 2015 - ashpublications.org
Waldenström macroglobulinemia (WM) is a B-cell neoplasm manifested by the accumulation
of clonal immunoglobulin (Ig) M-secreting lymphoplasmacytic cells. MYD88 and CXCR4 …
of clonal immunoglobulin (Ig) M-secreting lymphoplasmacytic cells. MYD88 and CXCR4 …